ReviewClinical cancer research : an official journal of the American Association for Cancer Research2026

The CD94/NKG2A-HLA-E Axis as a Target in Cancer Immunotherapy: A Critical Perspective.

Miguel López-Botet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.